Featured Research

from universities, journals, and other organizations

Oral Contraceptives Associated With Reduced Risk Of Multiple Sclerosis

Date:
September 29, 2005
Source:
JAMA and Archives Journals
Summary:
Over a three-year period, the risk of developing multiple sclerosis (MS) was reduced in women taking oral contraceptives, according to a study in the September issue of Archives of Neurology, one of the JAMA/Archives journals.

CHICAGO – Over a three-year period, the risk of developingmultiple sclerosis (MS) was reduced in women taking oralcontraceptives, according to a study in the September issue of Archivesof Neurology, one of the JAMA/Archives journals.

In previousstudies, estrogen delayed the onset and eased the course of a MS-likedisease in animals, suggesting that oral contraceptives, which containestrogen, and pregnancy and the postpartum period afterward, bothstates associated with profound hormonal changes, may alter theclinical course or affect the risk of developing the disease, accordingto background information in the article.

Αlvaro Alonso, M.D.,Ph.D., of the Harvard School of Public Health, Boston, and colleaguescompared 106 women who had a new diagnosis of MS between January 1,1993 and December 31, 2000 with 1,001 matched women without MS ascontrols. Individuals included in the analysis were drawn from aresearch database that includes medical and pharmacy records for threemillion Britons.

"The incidence of MS in OC [oral contraceptives]users was 40 percent lower than in nonusers," the authors report."Women had a higher risk of developing first symptoms of MS in the sixmonths following a pregnancy and a non-significant lower risk duringpregnancy, compared with those with no pregnancy. … This is consistentwith studies on the effect of pregnancy in patients with MS and theimmunological changes associated with pregnancy."

"Recent OC useand, possibly, current pregnancy are associated with a lower risk ofdeveloping MS," the authors conclude. "On the contrary, the postpartumperiod confers a higher risk of MS onset. Our findings suggest thathigh levels of exogenous [from outside the body] estrogens from OC useand of endogenous [from the body] estrogens during pregnancy may delaythe first clinical attack of MS."

###

(Arch Neurol. 2005; 62:1362-1365. Available pre-embargo to the media at www.jamamedia.org.)

Editor'sNote: This study was supported by a grant from the National MultipleSclerosis Society, New York, N.Y. Dr. Alonso was supported by aFulbright Program fellowship, New York.


Story Source:

The above story is based on materials provided by JAMA and Archives Journals. Note: Materials may be edited for content and length.


Cite This Page:

JAMA and Archives Journals. "Oral Contraceptives Associated With Reduced Risk Of Multiple Sclerosis." ScienceDaily. ScienceDaily, 29 September 2005. <www.sciencedaily.com/releases/2005/09/050929202016.htm>.
JAMA and Archives Journals. (2005, September 29). Oral Contraceptives Associated With Reduced Risk Of Multiple Sclerosis. ScienceDaily. Retrieved July 25, 2014 from www.sciencedaily.com/releases/2005/09/050929202016.htm
JAMA and Archives Journals. "Oral Contraceptives Associated With Reduced Risk Of Multiple Sclerosis." ScienceDaily. www.sciencedaily.com/releases/2005/09/050929202016.htm (accessed July 25, 2014).

Share This




More Health & Medicine News

Friday, July 25, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Beatings and Addiction: Pakistan Drug 'clinic' Tortures Patients

Beatings and Addiction: Pakistan Drug 'clinic' Tortures Patients

AFP (July 24, 2014) — A so-called drugs rehab 'clinic' is closed down in Pakistan after police find scores of ‘patients’ chained up alleging serial abuse. Duration 03:05 Video provided by AFP
Powered by NewsLook.com
Too Few Teens Receiving HPV Vaccination, CDC Says

Too Few Teens Receiving HPV Vaccination, CDC Says

Newsy (July 24, 2014) — The Centers for Disease Control and Prevention is blaming doctors for the low number of children being vaccinated for HPV. Video provided by Newsy
Powered by NewsLook.com
New Painkiller Designed To Discourage Abuse: Will It Work?

New Painkiller Designed To Discourage Abuse: Will It Work?

Newsy (July 24, 2014) — The FDA approved Targiniq ER on Wednesday, a painkiller designed to keep users from abusing it. Like any new medication, however, it has doubters. Video provided by Newsy
Powered by NewsLook.com
Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Newsy (July 24, 2014) — Sheik Umar Khan has treated many of the people infected in the Ebola outbreak, and now he's become one of them. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

    Health News

      Environment News

        Technology News



          Save/Print:
          Share:  

          Free Subscriptions


          Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

          Get Social & Mobile


          Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

          Have Feedback?


          Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
          Mobile iPhone Android Web
          Follow Facebook Twitter Google+
          Subscribe RSS Feeds Email Newsletters
          Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins